Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-JP-17
Country
JP
Application Type
DIV
Patent Status
Pending
Patent Number
Publication Number
2020-072720
Application Number
2020-001954
IC
NCI
Date Filed
Date Issued
Patent PDF